0
0 (0%)
Organicell Regenerative Medicine, Inc. [BPSR]
Source:
Company Overview
Zeo Scientifix, Inc is a clinical-stage biopharmaceutical company principally focusing on the development of innovative biological therapeutics for the treatment of degenerative diseases and regenerative medicine.
| Country | United States |
| Headquarters | davie, florida |
| Phone Number | 888-963-7881 |
| Industry | manufacturing |
| CEO | Harry Leider, M.D. |
| Website | www.organicell.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $1.1 |
| Operating Profit | $-1.3 |
| Net Income | $-1.2 |
| Net Cash | $0.1 |
Profit Ratios
| Gross Margin | $0.9 |
| Operating Margin | -115 |
| Profit as % of Revenues | -72.3% |
| Profit as % of Assets | -77.9% |
| Profit as % of Stockholder Equity | 68.9% |
Management Effectiveness
| Return on Equity | 68.9% |
| Return on Assets | -80.2% |
| Turnover Ratio | 68.3% |
| EBITA | $-1.3 |
Balance Sheet and Cash Flow Measures
| Total Assets | $1.6 |
| Total Liabilities | $3.4 |
| Operating Cash Flow | $0.1 |
| Investing Cash Flow | |
| Financing Cash Flow | $-0 |
